Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 4: Line 4:
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author (Target Completion Date)'''!!'''Associate Editor'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content Pending or Complete'''
!'''Author Content Pending or Complete'''
!'''Date Completed by Author'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Editor Reviewed (Date of Last Review)'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Fabiola Quintero-Rivera (FQR)
|
|PENDING
|PENDING
|
|
|Fabiola Quintero-Rivera (FQR)
|
|
|
|
Line 21: Line 23:
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 30: Line 33:
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 39: Line 43:
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 48: Line 53:
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 57: Line 63:
|Rebecca Smith (trainee) + faculty TBD
|Rebecca Smith (trainee) + faculty TBD
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 66: Line 73:
|Mark Evans (trainee), Fabiola Quintero-Rivera
|Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 75: Line 83:
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||
|'''''Mastocytosis'''''||'''''Overview'''''||
| ||FQR
|
|
|
|
|
| ||FQR
|
|
|
|
Line 91: Line 101:
|Thuy Phung
|Thuy Phung
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 100: Line 111:
|Shashi Shetty
|Shashi Shetty
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 109: Line 121:
|Thuy Phung
|Thuy Phung
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 117: Line 130:
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 125: Line 139:
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 133: Line 148:
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 141: Line 157:
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 149: Line 166:
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 159: Line 177:
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 169: Line 188:
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 177: Line 197:
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 185: Line 206:
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 193: Line 215:
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 201: Line 224:
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 209: Line 233:
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 217: Line 242:
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 225: Line 251:
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|
|FQR
|
|
|
|
|
|FQR
|
|
|
|
Line 233: Line 260:
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 241: Line 269:
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 249: Line 278:
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 257: Line 287:
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 265: Line 296:
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 273: Line 305:
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
Line 281: Line 314:
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
Line 289: Line 323:
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
Line 304: Line 340:
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|PENDING
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
| ||JH / MS
|PENDING
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|PENDING
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|PENDING
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
Line 361: Line 405:
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|JH / MS
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Need permission for figure?  Update WHO?
|Need permission for figure?  Update WHO?
|-
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
| ||JH / MS
|Complete
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
| ||JH / MS
|Complete
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Check reference format
|Check reference format
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|Check reference format
|Check reference format
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
|
|
|??
| ||JH / MS
| ||JH / MS
|??
|
|
|
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
|
|
|??
| ||JH / MS
| ||JH / MS
|??
|
|
|
|
|
Line 623: Line 704:
|Kay Weng Choy + Greg Conboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 633: Line 715:
|Daynna Wolff+Jessica Snider (Path Resident)
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|JH / MS
|
|PENDING
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 643: Line 726:
|Daynna Wolff+ Paige Woodham (Path Resident)
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|JH / MS
|
|PENDING
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
| ||Yassmine Akkari (YA)
|
|
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
Line 679: Line 767:
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|YA
|
|PENDING
|PENDING
|
|
|YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
Line 703: Line 794:
Lisa Smith + Yassmine Akkari
Lisa Smith + Yassmine Akkari
|
|
|YA
|
|Complete
|Complete
|
|
|YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
Line 725: Line 819:
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|YA
|
|Complete
|Complete
|
|
|YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
| ||YA
|
|
|
|
|
| ||YA
|
|
|
|
Line 770: Line 870:
|Helene Bruyere
|Helene Bruyere
|
|
|YA
|
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
| ||Snehal Patel (SP)
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
Line 792: Line 895:
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 800: Line 904:
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 808: Line 913:
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 816: Line 922:
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
Line 824: Line 931:
|Hairy Cell Leukemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
Line 832: Line 940:
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
Line 840: Line 949:
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
Line 848: Line 958:
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
Line 856: Line 967:
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 864: Line 976:
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Mu Heavy Chain  Disease||Disease||
|    Mu Heavy Chain  Disease||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease||
|   Gamma Heavy Chain  Disease||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain  Disease||Disease||
|    Alpha Heavy Chain  Disease||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 907: Line 1,025:
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 915: Line 1,034:
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 923: Line 1,043:
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 931: Line 1,052:
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 939: Line 1,061:
|    Plasmacytoma||Disease||Zhenya Tang
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|           Primary  Amyloidosis||Disease||
|           Primary  Amyloidosis||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||
|         POEMS Syndrome||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease||
|         TEMPI Syndrome||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 989: Line 1,118:
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||
|Nodal Marginal Zone Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 1,004: Line 1,135:
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,012: Line 1,144:
|Follicular Lymphoma||Disease||Ruthann Pfau
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,020: Line 1,153:
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,028: Line 1,162:
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,036: Line 1,171:
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,044: Line 1,180:
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 1,066: Line 1,205:
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|SP
|
|PENDING - due 8/15/20
|PENDING - due 8/15/20
|
|
|SP
|
|
|
|
Line 1,074: Line 1,214:
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|SP
|
|PENDING - due 8/31/20
|PENDING - due 8/31/20
|
|
|SP
|
|
|
|
Line 1,082: Line 1,223:
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
|
|
|SP
|
|PENDING - due 8/15/20
|PENDING - due 8/15/20
|
|
|SP
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
Line 1,097: Line 1,240:
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|Greg Corboy (GC)
|
|PENDING
|PENDING
|
|
|Greg Corboy (GC)
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|EBV-Positive Mucocutaneous Ulcer||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Lymphomatoid Granulomatosis||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
| ||GC
|Complete
|
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|Primary Effusion Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||
|   Multicentric Castleman  Disease||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Burkitt Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
| ||GC
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
| ||Snehal Patel (SP)
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
| ||SP
|PENDING
|
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
| ||SP
|PENDING
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
| ||SP
|PENDING
|
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease||
|Aggressive NK-cell Leukemia||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|    Severe Mosquito Bite  Allergy||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|Adult T-cell Leukemia/Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 1,357: Line 1,537:
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,365: Line 1,546:
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,373: Line 1,555:
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,381: Line 1,564:
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,389: Line 1,573:
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|PENDING
| ||SP
| ||SP
|PENDING
|
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||
|Mycosis Fungoides||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Sézary Syndrome||Disease||
|Sézary Syndrome||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Lymphomatoid  Papulosis||Disease||
|    Lymphomatoid  Papulosis||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 1,495: Line 1,694:
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,503: Line 1,703:
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
| ||SP
|
|
|
|
|
| ||SP
|
|
|
|
Line 1,518: Line 1,720:
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,526: Line 1,729:
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
Line 1,534: Line 1,738:
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
| ||Associate Editor??
|
|
|
|
|
| ||Associate Editor??
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||
|Lymphomas Associated with HIV Infection||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
Line 1,630: Line 1,847:
|
|
|PENDING
|PENDING
|
|
|
|
|
Line 1,635: Line 1,853:
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
|          Monomorphic  B-cell PTLD||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|          Monomorphic  T/NK-cell PTLD||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|Histiocytic Sarcoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease||
|   Langerhans Cell  Histiocytosis||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|   Langerhans Cell  Sarcoma||Disease||
|   Langerhans Cell  Sarcoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|Indeterminate Dendritic Cell Tumour||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Interdigitating Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|Follicular Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|Fibroblastic Reticular Cell Tumor||Disease||
| ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||
| ||
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
| || ||
|
|
|
| ||
| ||
|
|
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
|-
|-
| || ||
| || ||
| ||
|
|
|
|
|
|
|
|-
| || ||
| ||
| ||
|
|
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"